The role of gastrodin in the management of CNS‐related diseases: Underlying mechanisms to therapeutic perspectives
Phytotherapy Research · 2024
DOI: 10.1002/ptr.8314 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Phytotherapy Research, 2024. Verfasst von Xirui He und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Bioengineering, Zhuhai Campus, Zunyi Medical University, Zhuhai, China. Hauptthemen laut MEDLINE: Benzyl Alcohols, Glucosides, Central Nervous System Diseases, Gastrodia. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 118 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Science and Technology Projects of Guizhou Province, Academic New Seedling Cultivation and Innovation Exploration Project's Cultivation Project of Zunyi Medical University.
Abstract (Originalsprache)
Central nervous system (CNS)‐related diseases have a high mortality rate, are a serious threat to physical and mental health, and have always been an important area of research. Gastrodin, the main active metabolite of Gastrodia elata Blume, used in Chinese medicine and food, has a wide range of pharmacological effects, mostly related to CNS disorders. This review aims to systematically summarize and discuss the effects and underlying mechanisms of gastrodin in the treatment of CNS diseases, and to assess its potential for further development as a lead drug in both biomedicine and traditional Chinese medicine. Studies on the pharmacological effects of gastrodin on the CNS indicate that it may exert anti‐neurodegenerative, cerebrovascular protective, and ameliorative effects on diabetic encephalopathy, perioperative neurocognitive dysfunction, epilepsy, Tourette's syndrome, depression and anxiety, and sleep disorders through various mechanisms. To date, 110 gastrodin products have been approved for clinical use, but further multicenter clinical case–control studies are relatively scarce. Preclinical studies have confirmed that gastrodin can be used to treat CNS‐related disorders. However, important concerns need to be addressed in the context of likely non‐specific, assay interfering effects when gastrodin is studied using in vitro and in silico approaches, calling for a systematic assessment of the evidence to date. High‐quality clinical trials should have priority to evaluate the therapeutic safety and clinical efficacy of gastrodin. Further experimental research using appropriate in vivo models is also needed, focusing on neurodegenerative diseases, cerebral ischemic and hypoxic diseases, brain damage caused by methamphetamine or heavy metals, and epilepsy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Bioengineering, Zhuhai Campus, Zunyi Medical University, Zhuhai, China.
- Key laboratory of Western Resource Biology and Modern Biotechnology, Northwest University, Xi'an, China.
- UCL School of Pharmacy, Pharmacognosy & Phytotherapy, University College London, London, UK.
- College of Pharmaceutical Sciences, Southwest University, Chongqing, China.
- Clinical Medical College of Acupuncture Moxibustion and Rehabilitation, Guangzhou University of Chinese Medicine, Guangzhou, China.
- Department of Ortho- and MSK-Science, University College London, London, UK.
ORCID-Profile: Xirui He, Jingyi Gu, Michael Heinrich
Förderung
- National Natural Science Foundation of China
- Science and Technology Projects of Guizhou Province
- Academic New Seedling Cultivation and Innovation Exploration Project's Cultivation Project of Zunyi Medical University
- China Scholarship Council
- Guizhou Province Innovation and Entrepreneurship Training Programme for College Students Project
Zitieren
APA
He, X., Chen, X., Yang, Y., Gu, J., Xie, Y., Liu, Y., Hao, M., & Heinrich, M. (2024). The role of gastrodin in the management of CNS‐related diseases: Underlying mechanisms to therapeutic perspectives. Phytotherapy Research. https://doi.org/10.1002/ptr.8314
Vancouver
He X, Chen X, Yang Y, Gu J, Xie Y, Liu Y, et al. The role of gastrodin in the management of CNS‐related diseases: Underlying mechanisms to therapeutic perspectives. Phytotherapy Research. 2024. doi:10.1002/ptr.8314
BibTeX
@article{He2024,
author = {He, Xirui and Chen, Xufei and Yang, Yan and Gu, Jingyi and Xie, Yulu and Liu, Yujie and Hao, Man and Heinrich, Michael},
title = {The role of gastrodin in the management of CNS‐related diseases: Underlying mechanisms to therapeutic perspectives},
journal = {Phytotherapy Research},
year = {2024},
doi = {10.1002/ptr.8314}
}
EUVIMED